A comprehensive
study on the synthesis of 5-fluoroalkyl-substituted
isoxazoles starting from functionalized halogenoximes is reported.
One-pot metal-free [3 + 2] cycloaddition of CF3-substituted
alkenes and halogenoximes bearing ester, bromo, chloromethyl, and
protected amino groups was developed for the preparation of 5-trifluoromethylisoxazoles.
The target 3,5-disubstituted derivatives were obtained in a regioselective
manner in good to excellent yield on up to 130 g scale. 5-Fluoromethyl-
and 5-difluoromethylisoxazoles were synthesized by late-stage deoxofluorination
of the corresponding 5-hydroxymethyl or 5-formyl derivatives, respectively,
in turn prepared via metal-free cycloaddition of halogenoximes and
propargylic alcohol. An alternative approach based on nucleophilic
substitution in 5-bromomethyl derivatives was found to be more convenient
for the preparation of 5-fluoromethylisoxazoles. Reaction of isoxazole-5-carbaldehydes
with the Ruppert–Prakash reagent was used for the preparation
of (β,β,β-trifluoro-α-hydroxyethyl)isoxazoles.
Utility of described approaches was shown by multigram preparation
of side-chain functionalized mono-, di-, and trifluoromethylisoxazoles,
for example, fluorinated analogues of ABT-418 and ESI-09.
We investigated the
optical properties of heterocyclic azo dyes
with different side groups prepared: as powders, in PMMA matrix, and
side-chain polymers. We characterized the nonlinear optical effects
of these compounds by Z-scan and all-optical poling techniques and
supported these experiments with theoretical modeling. It was found
that these materials show strong two-photon absorption cross sections
exceeding 20 GM, which is 1 order of magnitude stronger than that
of similar materials (azobenzene and p-aminoazobenzene).
Our study reveals the dominant role of the side-chain system over
the guest–host one and stresses the importance of the substituent
in the efficiency of the poling process.
A series of NЈ- (3-amino-1H-isoindol-1-ylidene)alkyl (aryl,heteroaryl)carbohydrazides have been synthesized in good yields and their structure and conformational behavior in the solid state and in solution have been studied by X-ray crystallography, NMR spectroscopy, and quantum calculations. (E)/(Z) amide-type isomerism and the dependence of the iso-
An efficient synthesis (up to a 200 g scale) of 3hydroxypyrrolidin-2-ones bearing alkyl substituents or functional groups at the C-5 position is described. The reaction sequence started from 1,3-dipolar cycloaddition of in situ generated nitrile oxides with (meth-)acrylates into 3-substituted isoxazoline-5carboxylates. The catalytic hydrogenolysis of the isoxazoline N−O bond was optimal upon using H 2 (1 atm) at rt, with the following order of the catalyst activity: Pd−C > Pd(OH) 2 −C > Pt−C. The reactions with Pt−C were more selective for the synthesis of pyrrolidones, while Pd−C provided the fastest conversion rates. The stirring efficiency had a positive impact on conversion rather than elevated temperatures (up to 40 °C) or pressure (up to 50 atm). The diastereoselectivity was governed mainly by steric factors, with a dr of 1:1 to 3:1 (cis-and trans-isomers could be separated). Higher homologues (isoxazolinylacetates and -propanoates) were suitable for the synthesis of 6-or 7-substituted 4-hydroxypiperidones and 5-hydroxyazepanones, respectively. The proposed methods are tolerant to functional groups, including CF 3 (but not CHF 2 or CH 2 Cl), ester, and most N-Boc-protected amines. The utility of hydroxyl groups in lactams was shown by functional group transformations. Hydrogenolysis of C(5)-functionalized isoxazolines, bearing trimethylsilyl, phosphonate, or sulfone groups, was also studied to demonstrate limitations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.